NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
2.54
-0.07 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
2.58
1.58%
After-hours: Aug 15, 2025, 07:55 PM EDT

NLS Pharmaceutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-2.04M -7.62M -15.47M -16.5M -15.98M -11.95M -6.23M
Depreciation & Amortization
5.71K 5.71K 11.41K 11.41K 10.73K 10.05K 72.19M
Stock-Based Compensation
104.39 164.91 83.25 22.73 n/a n/a n/a
Other Working Capital
449.93K -473.86K 320.27K 990.55K 1.1M -875.26K -1.62M
Other Non-Cash Items
101.02K -681.66K 465.92K 364.64K -1.94M 2.48M 2.42M
Deferred Income Tax
n/a 728.28K 568.27K -160.01K n/a n/a n/a
Change in Working Capital
400.68K 265.89K 911.44K 1.63M 3.08M -3.17M -3.87M
Operating Cash Flow
-1.53M -7.3M -13.51M -13.88M -12.87M -14.94M -9.93M
Capital Expenditures
-2 n/a n/a n/a -6.8K -39.56K -32.76K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -7.6M -3.52M 4.07M -39.56K 99.52K
Debt Repayment
-194.72K n/a n/a n/a n/a -1.43K 646.91K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.63K 1.63K 13.81M 13.81M 3.55M 20.34M 16.21M
Financial Cash Flow
1.19M 1.63K 13.81M 17.4M 7.14M 20.34M 16.85M
Net Cash Flow
551.11K -6.4M 297.26K 3.52M -5.74M 5.34M 6.95M
Free Cash Flow
-1.53M -7.3M -13.51M -13.88M -12.87M -14.98M -9.96M